Catecholaminergic Polymorphic Ventricular Tachycardia
| dc.contributor.author | Refaat, Marwan M. | |
| dc.contributor.author | Hassanieh, Sylvana | |
| dc.contributor.author | Scheinman, Melvin M. | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.department | Biochemistry and Molecular Genetics | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:48:43Z | |
| dc.date.available | 2025-01-24T11:48:43Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a challenging and serious disease with a high incidence of sudden cardiac deaths. Patients with CPVT should not be exposed to physical or emotional exertion that might induce ventricular tachycardia. This article presents a case with CPVT and discusses the clinical features of the disease, its genetic background, and the management of CPVT. | |
| dc.identifier.doi | https://doi.org/10.1016/j.ccep.2015.10.035 | |
| dc.identifier.eid | 2-s2.0-84959912708 | |
| dc.identifier.pmid | 26920200 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30837 | |
| dc.language.iso | en | |
| dc.publisher | W.B. Saunders | |
| dc.relation.ispartof | Cardiac Electrophysiology Clinics | |
| dc.source | Medline | |
| dc.subject | Adult | |
| dc.subject | Electrocardiography | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Mutation | |
| dc.subject | Ryanodine receptor calcium release channel/genetics | |
| dc.subject | Syncope | |
| dc.subject | Tachycardia, ventricular | |
| dc.subject | Cardiac | |
| dc.subject | Catecholaminergic | |
| dc.subject | Polymorphic | |
| dc.subject | Ventricular tachycardia | |
| dc.title | Catecholaminergic Polymorphic Ventricular Tachycardia | |
| dc.type | Review |
Files
Original bundle
1 - 1 of 1